Evaluation of responses to cardiac imaging questions by the artificial intelligence large language model ChatGPT.

Purpose: To assess ChatGPT's ability as a resource for educating patients on various aspects of cardiac imaging, including diagnosis, imaging modalities, indications, interpretation of radiology reports, and management.
Methods: 30 questions were posed to ChatGPT-3.5 and ChatGPT-4 three times in three separate chat sessions. Responses were scored as correct, incorrect, or clinically misleading categories by three observers-two board certified cardiologists and one board certified radiologist with cardiac imaging subspecialization. Consistency of responses across the three sessions was also evaluated. Final categorization was based on majority vote between at least two of the three observers.
Results: ChatGPT-3.5 answered seventeen of twenty eight questions correctly (61 %) by majority vote. Twenty one of twenty eight questions were answered correctly (75 %) by ChatGPT-4 by majority vote. Majority vote for correctness was not achieved for two questions. Twenty six of thirty questions were answered consistently by ChatGPT-3.5 (87 %). Twenty nine of thirty questions were answered consistently by ChatGPT-4 (97 %). ChatGPT-3.5 had both consistent and correct responses to seventeen of twenty eight questions (61 %). ChatGPT-4 had both consistent and correct responses to twenty of twenty eight questions (71 %).
Conclusion: ChatGPT-4 had overall better performance than ChatGTP-3.5 when answering cardiac imaging questions with regard to correctness and consistency of responses. While both ChatGPT-3.5 and ChatGPT-4 answers over half of cardiac imaging questions correctly, inaccurate, clinically misleading and inconsistent responses suggest the need for further refinement before its application for educating patients about cardiac imaging.
Competing Interests: Declaration of competing interest Lorenzo Nardo, MD PhD, is the principal investigator (PI) of a service agreement with United Imaging Healthcare, site PI of clinical trials supported by Novartis Pharmaceuticals Corporation, PI of a clinical trial supported by Telix Pharmaceuticals, PI of a clinical trial supported by Lantheus Medical Imaging, and PI of a clinical trial supported by GE Healthcare. None of the other authors have any disclosures.
(Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)